Key facts
- Wuxi AppTec's first-half earnings have surged.
- The company is currently under scrutiny from the United States.
Chinese biotech firm Wuxi AppTec has reported a substantial increase in its earnings for the first half of the year. This financial growth comes at a time when the company is facing heightened scrutiny from the United States. Despite the ongoing geopolitical and regulatory pressures, Wuxi AppTec's performance indicates a strong operational capacity and market resilience.